Exact Mass: 572.317

Dolichyl D-xylosyl phosphate

alpha-(3-methylbut-2-en-1-yl)-omega-{4-[(D-xylopyranosyloxy)(hydroxy)phosphoryloxy]-2-methylbutyl}poly[(2E)-2-methylbut-2-ene-1,4-diyl]

C30H53O8P (572.3478)

Ganoderic acid H

6-(12-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid

Ganoderic acid H is found in mushrooms. Ganoderic acid H is from Ganoderma lucidum (reishi From Ganoderma lucidum (reishi). Ganoderic acid H is found in mushrooms. Ganoderic acid H is a triterpenoid.

LysoPI(16:0/0:0)

[(2R)-3-(hexadecanoyloxy)-2-hydroxypropoxy]({[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid

C25H49O12P (572.2961)

LysoPI(16:0/0:0) is a lysophosphatidylinositol. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylinositols can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPI(16:0/0:0), in particular, consists of one chain of palmitic acid at the C-1 position.

Bioadykinin Fragment 1-5

2-({2-[({1-[1-(2-amino-5-carbamimidamidopentanoyl)pyrrolidine-2-carbonyl]pyrrolidin-2-yl}(hydroxy)methylidene)amino]-1-hydroxyethylidene}amino)-3-phenylpropanoate

C27H40N8O6 (572.3071)

Chemistry 2

5-benzyl-4-(cyclohexylmethyl)-1-{4-[5,6-dioxo-1-(2-phenylethyl)piperazin-2-yl]butyl}piperazine-2,3-dione

C34H44N4O4 (572.3362)

Ile-Ile-Ala-Glu-Lys

6-Amino-2-[(2-{[2-({2-[(2-amino-1-hydroxy-3-methylpentylidene)amino]-1-hydroxy-3-methylpentylidene}amino)-1-hydroxypropylidene]amino}-4-carboxy-1-hydroxybutylidene)amino]hexanoate

6-[16-(acetyloxy)-5-hydroxy-2,6,6,11,15-pentamethyl-9,12,17-trioxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-1(10)-en-14-yl]-2-methyl-4-oxoheptanoic acid

LPI 16:0

1-hexadecanoyl-sn-glycero-3-phospho-(1-myo-inositol)

C25H49O12P (572.2961)

dolichyl-4-D-xylosyl phosphate

C30H53O8P (572.3478)

Formicolide A

MC-Val-Cit-PAB-OH

C28H40N6O7 (572.2958)

Atorvastatin methyl ester

C34H37FN2O5 (572.2686)

Adipic acid,phthalic anhydride,trimethylolpropane,2-ethylhexanoic acid polymer

Arenobufagin 3-hemisuberate

Tert-butyl((3s)-1-(7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl) Methyl)-2,6-dioxo-2,3,4,5,6,7-hexahydro-1h-purin-8-yl)piperidin-3-yl)carbaMate

C30H36N8O4 (572.2859)

Linagliptin Impurity 05

C30H36N8O4 (572.2859)

Dronedarone N-Oxide

C31H44N2O6S (572.292)

UK 370106

C35H44N2O5 (572.325)

Tazemetostat

Tazemetostat (EPZ-6438)

C34H44N4O4 (572.3362)

1-hexadecanoyl-sn-glycero-3-phospho-(1-myo-inositol)

C25H49O12P (572.2961)

H-DL-xiIle-DL-xiIle-DL-Ala-DL-Glu-DL-Lys-OH

C26H48N6O8 (572.3533)

Chemistry 2

C34H44N4O4 (572.3362)

CID 124202182

C28H36N12O2 (572.3084)

casearupestrin C

ethyl (2E,4S)-4-[(2S)-2-[(2S)-2-{[(benzyloxy)carbonyl]amino}-3-methylbutanamido]-4-methylpentanamido]-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate

C30H44N4O7 (572.321)

1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-3-(4-fluorophenyl)-1-methylurea

C31H45FN4O5 (572.3374)

Arg-Asn-Gln-Arg

3-(3-fluorophenyl)-1-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea

C33H37FN4O4 (572.2799)

(1R,9S,12S,13S,14S,19R,21S)-14-ethyl-9-[(1S,12S,14S,15E)-15-ethylidene-3,17-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4,6,8-tetraen-13-yl]-10-oxa-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6-triene

(1R,9S,12S,13S,14S,19R,21S)-14-ethyl-9-[(1S,12S,14S,15E)-15-ethylidene-3,17-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4,6,8-tetraen-13-yl]-10-oxa-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6-triene

A 1-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the acyl group is specified as hexadecanoyl (palmitoyl).

Casearupestrin C, (rel)-

ST 29:2;O6;S

C29H48O9S (572.3019)

Bradykinin (1-5)

C27H40N8O6 (572.3071)

Bradykinin (1-5) is a major stable metabolite of Bradykinin, formed by the proteolytic action of angiotensin-converting enzyme (ACE). Bradykinin (1-5) is a major stable metabolite of Bradykinin, formed by the proteolytic action of angiotensin-converting enzyme (ACE).

LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA)

C23H43F3N6O7 (572.3145)

LSKL, Inhibitor of Thrombospondin (TSP-1) TFA is a latency-associated protein (LAP)-TGFβ derived tetrapeptide and a competitive TGF-β1 antagonist. LSKL, Inhibitor of Thrombospondin (TSP-1) TFA inhibits the binding of TSP-1 to LAP and alleviates renal interstitial fibrosis and hepatic fibrosis. LSKL, Inhibitor of Thrombospondin (TSP-1) TFA suppresses subarachnoid fibrosis via inhibition of TSP-1-mediated TGF-β1 activity, prevents the development of chronic hydrocephalus and improves long-term neurocognitive defects following subarachnoid hemorrhage (SAH). LSKL, Inhibitor of Thrombospondin (TSP-1) TFA can readily crosse the blood-brain barrier[1][2].

SLLK, Control Peptide for TSP1 Inhibitor(TFA)

C23H43F3N6O7 (572.3145)

SLLK, Control Peptide for TSP1 Inhibitor (TFA) is a control peptide for LSKL, which is a Thrombospondin (TSP-1) inhibitor.

[(1s,2r,6r,10s,11r,13s,14r,15r)-13-(acetyloxy)-1,6-dihydroxy-4,12,12,15-tetramethyl-14-[(3-methylbutanoyl)oxy]-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-8-yl]methyl (2z)-2-methylbut-2-enoate

[(1s,2r,6r,10s,11r,13s,14r,15r)-13-(acetyloxy)-1,6-dihydroxy-4,12,12,15-tetramethyl-14-[(3-methylbutanoyl)oxy]-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-8-yl]methyl (2z)-2-methylbut-2-enoate

(2r)-2-[(1s,2r,4r,5r,6r,10r,13s,15s)-4-hydroxy-13-[(2-hydroxyacetyl)oxy]-2,6,10,14,14-pentamethyl-16,17-dioxapentacyclo[13.2.2.0¹,⁹.0²,⁶.0¹⁰,¹⁵]nonadeca-8,18-dien-5-yl]-6-methyl-5-methylideneheptanoic acid

(2r)-2-[(1s,2r,4r,5r,6r,10r,13s,15s)-4-hydroxy-13-[(2-hydroxyacetyl)oxy]-2,6,10,14,14-pentamethyl-16,17-dioxapentacyclo[13.2.2.0¹,⁹.0²,⁶.0¹⁰,¹⁵]nonadeca-8,18-dien-5-yl]-6-methyl-5-methylideneheptanoic acid

15',16'-bis(acetyloxy)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-19'-yl acetate

14,16-dihydroxy-4,15-dimethoxy-2,6,14,17-tetramethyl-11-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-3-one

[(1r,9r,10s,11r,13s,17r,25r,26s,27r,28e,33s,36s,38z,39s)-38-ethylidene-35-oxa-8,14,24,30-tetraazadodecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1⁹,²⁵.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁶.0²⁶,³⁹]nonatriaconta-2,4,6,18,20,22-hexaen-28-ylidene]methanol

[(1r,9r,10s,11r,13s,17r,25r,26s,27r,28e,33s,36s,38z,39s)-38-ethylidene-35-oxa-8,14,24,30-tetraazadodecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1⁹,²⁵.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁶.0²⁶,³⁹]nonatriaconta-2,4,6,18,20,22-hexaen-28-ylidene]methanol

C37H40N4O2 (572.3151)

3-[2-(2h-1,3-benzodioxol-5-yl)-4-[2-(2h-1,3-benzodioxol-5-yl)ethyl]-3-(piperidine-1-carbonyl)cyclobutyl]-1-(piperidin-1-yl)prop-2-en-1-one

C34H40N2O6 (572.2886)

6-[7-(acetyloxy)-11-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

methyl 10-(acetyloxy)-4-hydroxy-15-[3-(2-hydroxypropan-2-yl)-4-oxocyclopent-2-en-1-yl]-2,7,11,16-tetramethyl-5-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-ene-7-carboxylate

(2r)-2-hydroxy-3-{[(9s)-9-methylhexadecyl]oxy}propoxy([(1r,2s,3r,4r,5s,6s)-2,3,4,5,6-pentahydroxycyclohexyl]oxy)phosphinic acid

C26H53O11P (572.3325)

(1r,2s,6r,10s,11r,12s,13s,15r)-8-[(acetyloxy)methyl]-1,6-dihydroxy-4,12,15-trimethyl-12-{[(2-methylbutanoyl)oxy]methyl}-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl 2-methylbut-2-enoate

(1r,2s,6r,10s,11r,12s,13s,15r)-8-[(acetyloxy)methyl]-1,6-dihydroxy-4,12,15-trimethyl-12-{[(2-methylbutanoyl)oxy]methyl}-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl 2-methylbut-2-enoate

(1'r,2r,4's,5s,6r,8'r,10'e,13'r,14'e,16'e,20'r,21'r,24's)-6-ethyl-24'-hydroxy-22'-(hydroxymethyl)-21'-methoxy-5,11',13'-trimethyl-3',7',19'-trioxaspiro[oxane-2,6'-tetracyclo[15.6.1.1⁴,⁸.0²⁰,²⁴]pentacosane]-10',14',16',22'-tetraen-2'-one

(1'r,2r,4's,5s,6r,8'r,10'e,13'r,14'e,16'e,20'r,21'r,24's)-6-ethyl-24'-hydroxy-22'-(hydroxymethyl)-21'-methoxy-5,11',13'-trimethyl-3',7',19'-trioxaspiro[oxane-2,6'-tetracyclo[15.6.1.1⁴,⁸.0²⁰,²⁴]pentacosane]-10',14',16',22'-tetraen-2'-one

6-[11-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

(1s,2r,4s,6r,7s,10s,11r,18r)-18-hydroxy-7,11-dimethyl-6-[(1r)-1-[(1s,3r,5r)-5,6,6-trimethyl-1-[2-(methylsulfanyl)-2-oxoethyl]-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]-5-oxapentacyclo[8.8.0.0²,⁷.0⁴,⁶.0¹¹,¹⁶]octadeca-12,15-dien-14-one

(1s,2r,4s,6r,7s,10s,11r,18r)-18-hydroxy-7,11-dimethyl-6-[(1r)-1-[(1s,3r,5r)-5,6,6-trimethyl-1-[2-(methylsulfanyl)-2-oxoethyl]-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]-5-oxapentacyclo[8.8.0.0²,⁷.0⁴,⁶.0¹¹,¹⁶]octadeca-12,15-dien-14-one

C32H44O7S (572.2808)

(2z)-3-[(1r,2s,3s,4r)-2-(2h-1,3-benzodioxol-5-yl)-4-[2-(2h-1,3-benzodioxol-5-yl)ethyl]-3-(piperidine-1-carbonyl)cyclobutyl]-1-(piperidin-1-yl)prop-2-en-1-one

C34H40N2O6 (572.2886)

(1r,4s,8s,13r,14s,17r,22r)-4,9,9,14,17,20,20-heptamethyl-23-oxo-24-oxahexacyclo[11.9.2.0¹,¹⁴.0⁴,¹³.0⁵,¹⁰.0¹⁷,²²]tetracosa-5(10),11-dien-8-yl 2-hydroxybenzoate

C37H48O5 (572.3502)

3-({2-[(acetyloxy)methyl]-17-hexyl-3-hydroxy-6-oxo-hexadecahydropyrano[2,3-b]1,4-dioxacyclohexadecan-4-yl}oxy)-3-oxopropanoic acid

C29H48O11 (572.3196)

3-{2,10-dihydroxy-3b,6,6,9a,11a-pentamethyl-4,7-dioxo-1h,2h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-6-hydroxy-7,7-dimethyl-5-oxooxepan-2-yl acetate

1-[(1s,2s,5r,6r)-2-(2h-1,3-benzodioxol-5-yl)-6-[2-(2h-1,3-benzodioxol-5-yl)ethyl]-5-(piperidine-1-carbonyl)cyclohex-3-ene-1-carbonyl]piperidine

C34H40N2O6 (572.2886)

[(1s,4ar,6s,7r,7as)-6-(acetyloxy)-4a,7-dihydroxy-7-(methoxymethyl)-1-[(3-methylbutanoyl)oxy]-1h,5h,6h,7ah-cyclopenta[c]pyran-4-yl]methyl (2s)-3-methyl-2-[(3-methylbutanoyl)oxy]butanoate

10-ethenyl-13-ethyl-7-{15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl}-1,3-diazatetracyclo[11.3.1.0²,¹¹.0⁴,⁹]heptadeca-2,4,6,8,10-pentaen-6-ol

10-ethenyl-13-ethyl-7-{15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl}-1,3-diazatetracyclo[11.3.1.0²,¹¹.0⁴,⁹]heptadeca-2,4,6,8,10-pentaen-6-ol

C38H44N4O (572.3515)

(1'r,2r,2's,4's,7's,8'r,9's,12's,13'r,15'r,16'r,18's,19'r)-15',16'-bis(acetyloxy)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-19'-yl acetate

(1r,3s,5s,6r)-8-methyl-6-[(3-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (1s,3r,5r,6s)-8-methyl-6-[(3-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2z)-2-methylbut-2-enedioate

C31H44N2O8 (572.3098)

(1s,2s,6s,7s,9r,11s,13r,14s,15r,16s,17r)-14,16-dihydroxy-4,15-dimethoxy-2,6,14,17-tetramethyl-11-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-3-one

(1r,3r,4r,5r,7s,8s,9r,10e,12s,13s,14s)-9-(acetyloxy)-13-hydroxy-3,6,6,10,14-pentamethyl-8-{[(2e)-2-methylbut-2-enoyl]oxy}-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-4-yl (2e)-2-methylbut-2-enoate

1,5,11,15,21,25-hexahydroxy-1,6,11,16,21,26-hexaazacyclohentriaconta-5,15,25-triene-2,12,22-trione

C25H44N6O9 (572.317)

(2s,9r,13r,14s,15r,17r)-14,16-dihydroxy-4,15-dimethoxy-2,6,14,17-tetramethyl-11-{[(2s,4s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-3-one

(2s,9r,13r,14s,15r,17r)-14,16-dihydroxy-4,15-dimethoxy-2,6,14,17-tetramethyl-11-{[(2s,4s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-3-one

C30H40N2O9 (572.2734)

[6-(acetyloxy)-4a,7-dihydroxy-7-(methoxymethyl)-1-[(3-methylbutanoyl)oxy]-1h,5h,6h,7ah-cyclopenta[c]pyran-4-yl]methyl 3-methyl-2-[(3-methylbutanoyl)oxy]butanoate

(1'r,2r,4's,5s,6r,8'r,10'e,13'r,14'e,16'e,20'r,21'r,24's)-6-ethyl-6,24'-dihydroxy-21'-methoxy-5,11',13',22'-tetramethyl-3',7',19'-trioxaspiro[oxane-2,6'-tetracyclo[15.6.1.1⁴,⁸.0²⁰,²⁴]pentacosane]-10',14',16',22'-tetraen-2'-one

(1'r,2r,4's,5s,6r,8'r,10'e,13'r,14'e,16'e,20'r,21'r,24's)-6-ethyl-6,24'-dihydroxy-21'-methoxy-5,11',13',22'-tetramethyl-3',7',19'-trioxaspiro[oxane-2,6'-tetracyclo[15.6.1.1⁴,⁸.0²⁰,²⁴]pentacosane]-10',14',16',22'-tetraen-2'-one

(11e,13e)-16-ethyl-4,6,7-trihydroxy-15-{[(5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl)oxy]methyl}-5,9,13-trimethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

C29H48O11 (572.3196)

(2e,6r)-6-[(1r,3ar,4s,5ar,6r,9as,11r,11ar)-11-(acetyloxy)-4-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

(2e,6r)-6-[(1r,3ar,4s,5ar,6r,9as,11r,11ar)-11-(acetyloxy)-4-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

[(1s,2r,3r,4s,5s,6s,8r,9s,10s,13s,16r,17r,18s)-11-ethyl-4,8,9-trihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate

C31H44N2O8 (572.3098)

(2r,3s,6r)-3-[(1s,2r,3br,5ar,9as,9br,10r,11as)-2,10-dihydroxy-3b,6,6,9a,11a-pentamethyl-4,7-dioxo-1h,2h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-7,7-dimethyl-5-oxooxepan-2-yl acetate

(2r,3s,6r)-3-[(1s,2r,3br,5ar,9as,9br,10r,11as)-2,10-dihydroxy-3b,6,6,9a,11a-pentamethyl-4,7-dioxo-1h,2h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-7,7-dimethyl-5-oxooxepan-2-yl acetate